drugset / Trial / NCT00759564
A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function
Non-randomizedCrossoverOpen-label
Summary
This study will evaluate what effect renal dysfunction has on a drug that has an intravenous (CP-70,429) and an oral form (PF-03709270).
Timeline
- Start
- 2008-11
- Primary completion
- 2010-03
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sulopenem | Small molecule | 800 mg | Intravenous |
| Subject | sulopenem etzadroxil | Small molecule | 1000 mg | Oral |